210963-04-5

Basic information

• Product Name: Benzoic acid, 4-[[[(1,1-diMethylethoxy)carbonyl]MethylaMino]Methyl]-
• Synonyms: 4-[[Boc-(methylamino)]methyl]benzoic acid;4-(((tert-Butoxycarbonyl);4-((tert-butoxycarbonyl(Methyl)aMino)Methyl)benzoic acid;4-((tert-butoxycarbonyl)Methyl)benzoic acid;Benzoic acid, 4-[[[(1,1-diMethylethoxy)carbonyl]MethylaMino]Methyl]-
• CAS NO: 210963-04-5
• Molecular Formula: C₁₄H₁₉NO₄
• Molecular Weight: 265.30496
• EINECS: -0
• Mol File: 210963-04-5.mol

Chemical Properties

• Boiling Point: 402.9±34.0 °C(Predicted)
• Appearance: /
• Density: 1.163±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 4.28±0.10(Predicted)
• CAS DataBase Reference: Benzoic acid, 4-[[[(1,1-diMethylethoxy)carbonyl]MethylaMino]Methyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-[[[(1,1-diMethylethoxy)carbonyl]MethylaMino]Methyl]-(210963-04-5)
• EPA Substance Registry System: Benzoic acid, 4-[[[(1,1-diMethylethoxy)carbonyl]MethylaMino]Methyl]-(210963-04-5)

Safety Data

• Hazardous Substances Data: 210963-04-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical and Biotechnology Industries:
Benzoic acid, 4-[[[(1,1-dimethylethoxy)carbonyl]methylamino]methyl]-, is used as a building block for the synthesis of various compounds, including peptide and nucleic acid-based products. Its Boc-protected methylamino group allows for the controlled formation of amide bonds, which are crucial in the assembly of complex biologically active molecules.
Used as a Protecting Group in Organic Synthesis:
In organic synthesis, Benzoic acid, 4-[[[(1,1-dimethylethoxy)carbonyl]methylamino]methyl]-, serves as a protecting group to temporarily shield reactive functional groups from unwanted reactions. The Boc group can be selectively removed under mild acidic conditions, enabling chemists to control the reactivity of the molecule and prevent side reactions during the synthesis process.
Used in Drug Development:
Due to its unique molecular structure and properties, Benzoic acid, 4-[[[(1,1-dimethylethoxy)carbonyl]methylamino]methyl]-, has potential applications in the development of new drugs. Its ability to form stable amide bonds and act as a protecting group makes it a valuable component in the design and synthesis of pharmaceutical compounds with specific therapeutic targets.
Used in Material Science:
Benzoic acid, 4-[[[(1,1-dimethylethoxy)carbonyl]methylamino]methyl]-, may also find applications in the development of new materials due to its versatile chemical properties. Its potential use in the creation of novel polymers, coatings, or other materials with specific properties can contribute to advancements in various industries, such as electronics, textiles, and environmental protection.

Upstream product

• 33233-67-9 4-(tert-Butoxycarbonylaminomethyl)benzoic acid 
• 74-88-4 methyl iodide 

Downstream Products

• 1232424-08-6 tert-butyl 4-(2-(3-amino-6-bromopyrazine-2-carbonyl)hydrazinecarbonyl)benzyl(methyl)carbamate 
• 952709-13-6 tert-butyl 4-((R)-3-((S)-4-acetamido-1-(6-chloro-3'-ethylbiphenyl-2-yl)-1-hydroxybutyl)piperidine-1-carbonyl)benzyl(methyl)carbamate 
• 1070870-88-0 1,1-dimethylethyl {[4-({(3R)-3-[4-(acetylamino)-1-(6-chloro-3'-ethyl-2-biphenylyl)-1-hydroxybutyl]-1-piperidinyl}carbonyl)phenyl]methyl}methylcarbamate 
• 952709-14-7 methyl (S)-4-(6-chloro-3'-ethylbiphenyl-2-yl)-4-hydroxy-4-((R)-1-(4-(((N-t-butoxycarbonyl-N-methyl)amino)methyl)benzoyl)piperidin-3-yl)butylcarbamate 

Relevant articles and documents

RENIN INHIBITORS

Described are compounds which bind to aspartic proteases to inhibit their activity. They are useful in the treatment or amelioration of diseases associated with aspartic protease activity. Also described are methods of use of the compounds described herein in ameliorating or treating aspartic protease related disorders in a subject in need thereof.

RENIN INHIBITORS

Disclosed are compounds of Formula (I) wherein the R, R1, R2, R3, X, Y, A, Q, E, and G are defined herein. These compounds bind to aspartic proteases to inhibit their activity and are useful in the treatment or amelioration of diseases associated with aspartic protease activity. Also disclosed are methods of use of the compounds of Formula I for ameliorating or treating aspartic protease related disorders in a subject in need thereof.

TETRAPEPTIDE INHIBITORS OF BETA-SECRETASE

Statine-derived peptide inhibitors of the β-secretase enzyme are provided which are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of Aβ peptide in a mammal. The compounds of the invention provide useful meth

Non-covalent polyvalent ligands by self-assembly of small glycodendrimers: A novel concept for the inhibition of polyvalent carbohydrate-protein interactions in vitro and in vivo

Polyvalent carbohydrate-protein interactions occur frequently in biology, particularly in recognition events on cellular membranes. Collectively, they can be much stronger than corresponding monovalent interactions, rendering it difficult to control them with individual small molecules. Artificial macromolecules have been used as polyvalent ligands to inhibit polyvalent processes; however, both reproducible synthesis and appropriate characterization of such complex entities is demanding. Herein, we present an alternative concept avoiding conventional macromolecules. Small glycodendrimers which fulfill single molecule entity criteria self-assemble to form non-covalent nanoparticles. These particles - not the individual molecules - function as polyvalent ligands, efficiently inhibiting polyvalent processes both in vitro and in vivo. The synthesis and characterization of these glycodendrimers is described in detail. Furthermore, we report on the characterization of the non-covalent nanoparticles formed and on their biological evaluation.

BENZAMIDINE DERIVATIVES

Benzamidine derivatives of the following formulae or analogs thereof, i. e., pharmaceutically acceptable salts thereof, are provided. These compounds or salts thereof have a blood-coagulation inhibiting effect based on an excellent effect of inhibiting the action of activated blood coagulation factor X, and they are useful as anticoagulants.